CORC

浏览/检索结果: 共28条,第1-10条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Xu, B.;  Luk, A.;  Liu, S.;  Jiang, W.;  Liu, E.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Phase III trial of chidamide, a subtype-selective histone deacetylase (HDAC) inhibitor, in combination with exemestane in patients with hormone receptor-positive advanced breast cancer 会议论文
作者:  Jiang, Z.;  Li, W.;  Hu, X.;  Zhang, Q.;  Sun, T.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Circulating Tumor DNA Clearance During Treatment Associates with Improved Progression-Free Survival 会议论文
作者:  Lu, S.;  Song, Y.;  Xie, Z.;  Zhu, Z.;  Liu, L.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Decreased expression of interleukin-27 in moderate-to-severe psoriasis and its anti-inflammatory role in an imiquimod-induced psoriasis-like mouse model 会议论文
作者:  Chen, W.;  Gong, Y.;  Zhang, X.;  Tong, Y.;  Wang, X.
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
etDNA: Tumor-Derived DNA from Pleural Effusion Supernatant as a Promising Source for NGS-Based Mutation Profiling in Lung Cancer 会议论文
作者:  Tong, L.;  Ding, N.;  Li, J.;  Wang, X.;  Zhang, Y.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Genome-wide microRNA expression profiling in malignant pleural effusion to identify a ten-microRNA signature. 会议论文
作者:  Zhang, Xin;  Zhang, Meiling;  Zhu, Miaojun;  Hu, Qin;  Li, Chun
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
XIPE the X-ray Imaging Polarimetry Explorer 会议论文
作者:  Soffitta, P.;  Bellazzini, R.;  Bozzo, E.;  Burwitz, V;  Castro-Tirado, A. J.
收藏  |  浏览/下载:43/0  |  提交时间:2019/12/05
Secular Trends Of Health-related Fitness Of Chinese College Students: A 12-year Follow-up Study 会议论文
作者:  Zhang, Zhen;  Chen, Zezhao;  Wu, Tong;  Zhu, Weimo
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
T3 Subclassification With EMD/Mesorectum Ratio Predicts Neoadjuvant Chemoradiation Outcome in T3 Rectal Cancer Patients 会议论文
作者:  Shen, L.;  Sun, Y.;  Tong, T.;  Zhang, H.;  Liang, L.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/13
A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit for the 会议论文
作者:  Jiang, Zefei;  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li
收藏  |  浏览/下载:59/0  |  提交时间:2019/12/13


©版权所有 ©2017 CSpace - Powered by CSpace